vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
31.31
+1.19 (3.95%)
At close: Aug 17, 2026, 4:00 PM EDT
31.31
0.00 (0.00%)
After-hours: Aug 17, 2026, 4:10 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $389.02 million as of August 17, 2026. Its market cap has increased by 282.46% in one year.
Market Cap
389.02M
Enterprise Value
302.38M
1-Year Change
282.46%
Ranking
Category
Stock Price
$31.31
ChartMarket Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $389.02M, an increase of 397.95%. That is a compound annual growth rate of 15.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 389.02M | -21.60% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 402.09M |
| Lexeo Therapeutics | 397.09M |
| Scribe Therapeutics | 391.06M |
| Upstream Bio | 387.23M |
| Capricor Therapeutics | 386.62M |
| Enanta Pharmaceuticals | 383.29M |
| Rocket Pharmaceuticals | 380.92M |
| Palisade Bio | 372.94M |